Cargando…

How Does the Canadian General Public Rate Moderate Alzheimer's Disease?

Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarride, Jean-Eric, Oremus, Mark, Pullenayegum, Eleanor, Clayton, Natasha, Raina, Parminder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250621/
https://www.ncbi.nlm.nih.gov/pubmed/22229093
http://dx.doi.org/10.4061/2011/682470
_version_ 1782220493924859904
author Tarride, Jean-Eric
Oremus, Mark
Pullenayegum, Eleanor
Clayton, Natasha
Raina, Parminder
author_facet Tarride, Jean-Eric
Oremus, Mark
Pullenayegum, Eleanor
Clayton, Natasha
Raina, Parminder
author_sort Tarride, Jean-Eric
collection PubMed
description Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD.
format Online
Article
Text
id pubmed-3250621
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-32506212012-01-06 How Does the Canadian General Public Rate Moderate Alzheimer's Disease? Tarride, Jean-Eric Oremus, Mark Pullenayegum, Eleanor Clayton, Natasha Raina, Parminder J Aging Res Research Article Objectives. The objectives of this study were to elicit health utility scores for moderate Alzheimer's disease (AD) using members of the general public. Methods. Five-hundred Canadians were chosen randomly to participate in a telephone interview. The EQ-5D was administered to estimate the health utility score for respondents' current health status (i.e., no AD) and for a hypothetical moderate AD health state. Regression analyses were conducted to explain the perceived utility decrement associated with AD. Results. The mean age of the respondents was 51 years, 60% were female, and 42% knew someone with AD. Respondents' mean EQ-5D scores for their current health status and a hypothetical moderate AD were 0.873 (SD: 0.138) and 0.638 (SD: 0.194), respectively (P < 0.001). Age, gender, and education were significant factors explaining this decrement in utility. Conclusion. Members of the general public may serve as an alternative to patients and caregivers in the elicitation of health-related quality of life in AD. SAGE-Hindawi Access to Research 2011 2011-12-20 /pmc/articles/PMC3250621/ /pubmed/22229093 http://dx.doi.org/10.4061/2011/682470 Text en Copyright © 2011 Jean-Eric Tarride et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tarride, Jean-Eric
Oremus, Mark
Pullenayegum, Eleanor
Clayton, Natasha
Raina, Parminder
How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_full How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_fullStr How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_full_unstemmed How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_short How Does the Canadian General Public Rate Moderate Alzheimer's Disease?
title_sort how does the canadian general public rate moderate alzheimer's disease?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250621/
https://www.ncbi.nlm.nih.gov/pubmed/22229093
http://dx.doi.org/10.4061/2011/682470
work_keys_str_mv AT tarridejeaneric howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT oremusmark howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT pullenayegumeleanor howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT claytonnatasha howdoesthecanadiangeneralpublicratemoderatealzheimersdisease
AT rainaparminder howdoesthecanadiangeneralpublicratemoderatealzheimersdisease